Welcome to our dedicated page for Jbg Smith Proper news (Ticker: JBGS), a resource for investors and traders seeking the latest updates and insights on Jbg Smith Proper stock.
JBG SMITH Properties owns, operates, invests in and develops mixed-use real estate concentrated in amenity-rich, Metro-served submarkets in and around Washington, DC, with a notable concentration in National Landing. The company’s portfolio spans multifamily, office and retail assets, and it also reports on a mixed-use development pipeline and third-party real estate services activity.
Recurring news for JBGS includes quarterly and annual results, Form 10-Q and Form 10-K releases, dividend declarations, leasing and occupancy trends, annualized NOI and same-store NOI, rent activity in the multifamily portfolio, property operating expenses, asset sales or acquisitions, and development deliveries within its Washington, DC-area real estate platform.
JBG SMITH (NYSE: JBGS) has postponed the release of its second quarter 2026 financial results, originally scheduled for August 4, 2026. The delay follows a July 31, 2026 judgment by the Superior Court of the District of Columbia in litigation over the Wardman Tower condominium project.
The court awarded $118.7 million in damages and ordered defendants, including the Company and its Operating Partnership, to pay treble that amount, or about $356 million, plus attorneys’ fees. JBG SMITH disputes the judgment, plans to appeal, and is assessing its impact, expecting to release results on or before August 10, 2026.
JBG SMITH (NYSE: JBGS) announced that its Board of Trustees has declared a quarterly cash dividend of $0.175 per common share. The dividend is scheduled to be paid on August 27, 2026 to common shareholders of record as of August 13, 2026.
American Healthcare REIT (NYSE: AHR) announced a leadership transition effective immediately. Jeff Hanson, previously Interim CEO and longtime Chairman, has been appointed Chief Executive Officer. Gabe Willhite, currently Chief Operating Officer, has been elevated to President. Company co-founder Danny Prosky has retired from his President and CEO roles but remains on the Board and will continue as an advisor to management.
The Board also named independent director Scott Estes as Lead Independent Director. According to American Healthcare REIT, these moves are intended to support the company’s next phase of growth, platform scaling and corporate governance strength.
JBG SMITH (NYSE: JBGS) announced it will release its second quarter 2026 financial results after the close of trading on August 4, 2026. The company said its quarterly investor package, including the earnings release, will be available on its Investor Relations website at investors.jbgsmith.com.
JBG SMITH (NYSE: JBGS) reported first quarter 2026 results for the period ended March 31, 2026. Net loss attributable to common shareholders was $18.7 million (loss per diluted share $0.32). FFO was $2.1 million ($0.04 per share) and Core FFO was $9.8 million ($0.17 per share).
Annualized NOI at our share was $249.7 million; Same Store NOI declined 4.8% to $54.3 million. Operating multifamily leased/occupied were 86.8%/84.5%; commercial leased/occupied 76.9%/75.2%. Net Debt / TEV was 70.3% and Net Debt / Adjusted EBITDA was 12.7x.
JBG SMITH (NYSE: JBGS) announced a quarterly common dividend of $0.175 per share. The Board declared the dividend to be paid on May 28, 2026 to shareholders of record as of May 14, 2026.
JBG SMITH (NYSE: JBGS) will report first quarter 2026 results after the close of trading on May 5, 2026. The company said its quarterly investor package and earnings release will be available in the Investor Relations section at investors.jbgsmith.com.
Investors can access the report and supplemental materials on that date for financial details and management commentary.
JBG SMITH (NYSE: JBGS) reported fourth-quarter and full-year 2025 results, filing its Form 10-K for the year ended December 31, 2025. Q4 net loss was $45.5 million and 2025 net loss was $139.1 million. Annualized NOI was $245.3 million for Q4. Operating multifamily was 84.7% leased and 82.7% occupied as of December 31, 2025.
Core FFO was $9.9 million for Q4 and $38.9 million for 2025. Net debt/total enterprise value was 66.5% and Net Debt to annualized Adjusted EBITDA was 12.5x as of December 31, 2025.
JBG SMITH (NYSE: JBGS) will report fourth quarter and year-end 2025 financial results after market close on February 17, 2026. The company said its quarterly investor package, including the earnings release, will be available on its investor relations website at investors.jbgsmith.com.
Investors can review the investor package online after the close for results, commentary, and supplemental materials.
JBG SMITH (NYSE: JBGS) announced a quarterly common dividend of $0.175 per share. The Board of Trustees declared the dividend, which will be paid on January 13, 2026 to common shareholders of record as of December 30, 2025.